Loading clinical trials...
Loading clinical trials...
A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Conditions
Interventions
Carboplatin
Paclitaxel
+1 more
Locations
29
United States
Research Site
Fountain Valley, California, United States
Research Site
Oxnard, California, United States
Research Site
Chicago, Illinois, United States
Research Site
Lafayette, Indiana, United States
Research Site
Baton Rouge, Louisiana, United States
Research Site
Annapolis, Maryland, United States
Start Date
December 16, 2010
Primary Completion Date
September 11, 2013
Completion Date
September 11, 2013
Last Updated
December 23, 2020
NCT06043817
NCT07144280
NCT06758401
NCT07431827
NCT06427941
NCT06476808
Lead Sponsor
MedImmune LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions